Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-26T10:05:38.164Z Has data issue: false hasContentIssue false

Chapter 16 - Neuromuscular Disorders in the Neurocritical Care Unit

Published online by Cambridge University Press:  24 July 2019

Michel T. Torbey
Affiliation:
Ohio State University
Get access

Summary

Neuromuscular diseases and respiratory failure are common problems encountered in both neurologic and medical intensive care units. Neuromuscular respiratory failure can be caused by diseases of the motor neuron, peripheral nerve, neuromuscular junction, or muscle. Thus, localization of the disorder is essential for adequate management.

Type
Chapter
Information
Neurocritical Care , pp. 188 - 198
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wijdicks, EFM (2002). Short of breath, short of air, short of mechanics. Pract Neurol 2: 208213.Google Scholar
Ragette, R, Mellies, U, Schwake, C et al. (2002). Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 57: 724728.Google Scholar
Gibson, GJ, Pride, NB, Davis, JN, et al. (1977). Pulmonary mechanics in patients with respiratory muscle weakness. Am Rev Respir Dis 115: 389395.Google Scholar
Flower, O, Bowles, C, Wijdicks, E, Weingart, SD, Smith, WS (2012). Emergency neurological life support: acute non-traumatic weakness. Neurocrit Care 17: 879895.Google Scholar
Serrano, MC, Rabinstein, AA (2010). Causes and outcomes of acute neuromuscular respiratory failure. Arch Neurol 67(9): 10891094.Google Scholar
Rabinstein, AA, Wijdicks, EF (2003). Warning signs of imminent respiratory failure in neurological patients. Semin Neurol 23(1): 97104.Google Scholar
Serrano, MC, Rabinstein, AA (2012). Usefulness of pulmonary function tests and blood gases in acute neuromuscular respiratory failure. Eur J Neurol 19: 452456.Google Scholar
Lawn, ND, Fletcher, DD, Henderson, RD, Wolter, TD, Wijdicks, EF (2001). Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 58: 893898.CrossRefGoogle ScholarPubMed
Yuki, N, Hartung, HP (2012). Guillain-Barré syndrome. N Engl J Med 366: 22942304.Google Scholar
Govoni, V., Granieri, E (2001). Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14: 605613.Google Scholar
Haber, P, DeStefano, F, Angulo, FJ, et al. (2004). Guillain-Barré syndrome following influenza vaccination. JAMA 292: 24782481.CrossRefGoogle ScholarPubMed
Gabriel, CM, Gregson, NA, Redford, EJ, et al. (1997). Human immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain.;120:15331540.Google Scholar
Hafer-Macko, C, Hsieh, ST, Li, CY, et al. (1996). Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40: 635644.Google Scholar
Walgaard, C, Lingsma, HF, Ruts, L, et al. (2010). Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol 67: 781787.Google Scholar
Asbury, AK, Cornblath, DR (1990). Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl): S21S24.Google Scholar
Pfeiffer, G, Schiller, B, Kruse, J, Netzer, J (1999). Indicators of dysautonomia in severe Guillain-Barré syndrome. J Neurol 246: 10151022.Google Scholar
Ropper, AH, Wijdicks, EF, Shahani, BT. (1990). Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome. Arch Neurol, 47: 881887.Google Scholar
Wijdicks, EFM, Henderson, RD, McClelland, RL. (2003). Emergency intubation for respiratory failure in Guillain-Barré syndrome. Arch Neurol, 60: 947948.Google Scholar
Wijdicks, EF, Roy, TK. (2006). BiPAP in early Guillain-Barré syndrome may fail. Can J Neurol Sci, 33:105106.Google Scholar
Lawn, ND, Wijdicks, EFM. (2000). Post-intubation pulmonary function test in Guillain-Barré syndrome. Muscle Nerve, 23: 613616.Google Scholar
Henderson, RD, Lawn, ND, Fletcher, DD, McClelland, RL, Wijdicks, EF. (2003). The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology, 60: 1721.Google Scholar
Raphaël, JC, Chevret, S, Hughes, RA, Annane, D. (2012). Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev, (7): CD001798.Google Scholar
Hughes, RA, Swan, AV, van Doorn, PA. (2012). Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev, (7): CD002063.Google Scholar
Kuitwaard, K, de Gelder, J, Tio-Gillen, AP, et al. (2009). Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol, 66: 597603.Google Scholar
Farcas, P, Avun, L, Frisher, S, Herishanu, YO, Wirguin, I. (1997). Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome. Lancet, 350(9093): 1747.CrossRefGoogle ScholarPubMed
Hughes, RA, van Doorn, PA. (2012). Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev, (7): CD00446.Google Scholar
Silvestri, NJ, Wolfe, GI. (2012). Myasthenia gravis. Semin Neurol, 32: 215226.Google Scholar
Thomas, CE, Mayer, SA, Gungor, Y, et al. (1997). Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology, 48: 12531260.Google Scholar
Meriggioli, MN. (2009). Myasthenia gravis: Immunopathogenesis, diagnosis, and management. Continuum Lifelong Learning Neurol, 15: 3562.Google Scholar
Filchrist, JM, Massey, JM, Sanders, DB. (1994). Single-fiber EMG and repetitive stimulation of the same muscle in myasthenia gravis. Muscle Nerve, 17: 171175.Google Scholar
Rabinstein, AA, Wijdicks, EFM. (2002). BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology, 59: 16471649.Google Scholar
Senevirante, J, Mandrekar, J, Wijdicks, EFM, Rabinstein, AA. (2008). Noninvasive ventilation in myasthenic crisis. Arch Neurol, 65: 5458.Google Scholar
Raphaël, JC, Chevret, S, Hughes, RA, Annane, D. (2002). Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev, (2): CD001798.Google Scholar
Gajdos, P, Chevret, S, Toyka, KV. (2012). Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev, (12): CD002277.Google Scholar
Gajdos, P, Chevret, S, Clair, B, Tranchant, C, Chastang, C. (1997). Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. MG Clinical Study Group. Ann Neurol, 41: 789796.Google Scholar
Barth, D, Nabavi Nouri, M, Ng, E, Nwe, P, Bril, V. (2011). Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology, 76: 20172023.CrossRefGoogle ScholarPubMed
Stricker, RB, Kwiatkowska, BJ, Habis, JA, Kiprov, DD. (1993). Myasthenic crisis: response to plasmapheresis following failure of intravenous gamma-globulin. Arch Neurol, 50: 837840.Google Scholar
Collongues, N, Casez, O, Lacour, A, et al. (2012). Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study. Muscle Nerve, 46: 687691.Google Scholar
Diaz-Manera, J, Martinez-Hernandez, E, Querol, L et al. (2012). Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology, 78: 189193.Google Scholar
Stevens, RD, Marshall, SA, Cornblath, DR, et al. (2009). A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med, 37(10 Suppl): S299S308.Google Scholar
Latronico, N, Bolton, CF. (2011). Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol, 10: 931941.Google Scholar
Bolton, CF, Gilbert, JJ, Hahn, AF, Sibbald, WJ. (1984). Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry, 47: 12231231.CrossRefGoogle ScholarPubMed
Bolton, CF. (2005). Neuromuscular manifestations of critical illness. Muscle Nerve, 32: 140163.CrossRefGoogle ScholarPubMed
Lacomis, D. (2013). Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve, 47: 452463.CrossRefGoogle ScholarPubMed
Goodman, B P, Harper, C M, Boon, A J. (2009). Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve, 40: 10401042.Google Scholar
Hermans, G, De Jonghe, B, Bruyninckx, F, Van den Berghe, G. (2014). Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev, (1): CD006832.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×